Liver function and drug processing: a new study
NCT ID NCT03289234
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 15 times
Summary
This study looked at how the body handles a single dose of the drug MCI-186 in people with mild or moderate liver impairment compared to those with healthy livers. A total of 22 participants received one intravenous infusion. The goal was to measure drug levels in the blood to understand any differences caused by liver function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational site
Fukuoka, Japan
-
Investigational site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.